{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:07:43Z","timestamp":1789564063796,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011002","name":"National Science Foundation of China | National Natural Science Foundation of China-Yunnan Joint Fund","doi-asserted-by":"publisher","award":["32122018"],"award-info":[{"award-number":["32122018"]}],"id":[{"id":"10.13039\/501100011002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ensuring genome safety during gene editing is crucial for clinical translation of the high-efficient CRISPR-Cas9 toolbox. Therefore, the undesired events including chromosomal translocations, vector integrations, and large deletions arising during therapeutic gene editing remain to be adequately addressed or tackled in vivo. Here, we apply CRISPR-Cas9TX in comparison to CRISPR-Cas9 to target <jats:italic>Vegfa<\/jats:italic> for the treatment of age-related macular degeneration (AMD) disease in a mouse model. AAV delivery of both CRISPR-Cas9 and CRISPR-Cas9TX can efficiently inhibit laser-induced neovascularization. Importantly, Cas9TX almost eliminates chromosomal translocations that occur at a frequency of approximately 1% in Cas9-edited mouse retinal cells. Strikingly, the widely observed AAV integration at the target <jats:italic>Vegfa<\/jats:italic> site is also greatly reduced from nearly 50% of edited events to the background level during Cas9TX editing. Our findings reveal that chromosomal structural variations routinely occur during in vivo genome editing and highlight Cas9TX as a superior form of Cas9 for in vivo gene disruption.<\/jats:p>","DOI":"10.1038\/s41467-022-35640-4","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T06:02:31Z","timestamp":1671688951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Safeguarding genome integrity during gene-editing therapy in a mouse model of age-related macular degeneration"],"prefix":"10.1038","volume":"13","author":[{"given":"Jianhang","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiong","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changchang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-633X","authenticated-orcid":false,"given":"Jiaxu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-722X","authenticated-orcid":false,"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6345-0039","authenticated-orcid":false,"given":"Jiazhi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"35640_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","volume":"25","author":"ML Maeder","year":"2019","unstructured":"Maeder, M. L. et al. Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. Nat. Med 25, 229\u2013233 (2019).","journal-title":"Nat. Med"},{"key":"35640_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41591-019-0343-4","volume":"25","author":"E Beyret","year":"2019","unstructured":"Beyret, E. et al. Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome. Nat. Med 25, 419\u2013422 (2019).","journal-title":"Nat. Med"},{"key":"35640_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41591-018-0338-6","volume":"25","author":"O Santiago-Fernandez","year":"2019","unstructured":"Santiago-Fernandez, O. et al. Development of a CRISPR\/Cas9-based therapy for Hutchinson-Gilford progeria syndrome. Nat. Med 25, 423\u2013426 (2019).","journal-title":"Nat. Med"},{"key":"35640_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41591-019-0738-2","volume":"26","author":"A Moretti","year":"2020","unstructured":"Moretti, A. et al. Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy. Nat. Med 26, 207\u2013214 (2020).","journal-title":"Nat. Med"},{"key":"35640_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.aad5177","volume":"351","author":"M Tabebordbar","year":"2016","unstructured":"Tabebordbar, M. et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351, 407\u2013411 (2016).","journal-title":"Science"},{"key":"35640_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765\u2013771 (2018).","journal-title":"Nat. Biotechnol."},{"key":"35640_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15464","volume":"8","author":"HY Shin","year":"2017","unstructured":"Shin, H. Y. et al. CRISPR\/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome. Nat. Commun. 8, 15464 (2017).","journal-title":"Nat. Commun."},{"key":"35640_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09006-2","volume":"10","author":"G Cullot","year":"2019","unstructured":"Cullot, G. et al. CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations. Nat. Commun. 10, 1136 (2019).","journal-title":"Nat. Commun."},{"key":"35640_CR9","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1038\/s41586-018-0380-z","volume":"560","author":"F Adikusuma","year":"2018","unstructured":"Adikusuma, F. et al. Large deletions induced by Cas9 cleavage. Nature 560, E8\u2013E9 (2018).","journal-title":"Nature"},{"key":"35640_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28900-w","volume":"13","author":"J Yin","year":"2022","unstructured":"Yin, J. et al. Cas9 exo-endonuclease eliminates chromosomal translocations during genome editing. Nat. Commun. 13, 1204 (2022).","journal-title":"Nat. Commun."},{"key":"35640_CR11","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3724\/abbs.2022056","volume":"54","author":"J Yin","year":"2022","unstructured":"Yin, J. & Hu, J. The origin of unwanted editing byproducts in gene editing. Acta Biochim Biophys. Sin. (Shanghai) 54, 767\u2013781 (2022).","journal-title":"Acta Biochim Biophys. Sin. (Shanghai)"},{"key":"35640_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41587-019-0394-6","volume":"38","author":"AL Norris","year":"2020","unstructured":"Norris, A. L. et al. Template plasmid integration in germline genome-edited cattle. Nat. Biotechnol. 38, 163\u2013164 (2020).","journal-title":"Nat. Biotechnol."},{"key":"35640_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12449-2","volume":"10","author":"KS Hanlon","year":"2019","unstructured":"Hanlon, K. S. et al. High levels of AAV vector integration into CRISPR-induced DNA breaks. Nat. Commun. 10, 4439 (2019).","journal-title":"Nat. Commun."},{"key":"35640_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","volume":"25","author":"CE Nelson","year":"2019","unstructured":"Nelson, C. E. et al. Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nat. Med 25, 427\u2013432 (2019).","journal-title":"Nat. Med"},{"key":"35640_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cell.2013.01.007","volume":"152","author":"FW Alt","year":"2013","unstructured":"Alt, F. W., Zhang, Y., Meng, F. L., Guo, C. & Schwer, B. Mechanisms of programmed DNA lesions and genomic instability in the immune system. Cell 152, 417\u2013429 (2013).","journal-title":"Cell"},{"key":"35640_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2010.03.016","volume":"141","author":"A Nussenzweig","year":"2010","unstructured":"Nussenzweig, A. & Nussenzweig, M. C. Origin of chromosomal translocations in lymphoid cancer. Cell 141, 27\u201338 (2010).","journal-title":"Cell"},{"key":"35640_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc1589","volume":"5","author":"R Kuppers","year":"2005","unstructured":"Kuppers, R. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 5, 251\u2013262 (2005).","journal-title":"Nat. Rev. Cancer"},{"key":"35640_CR18","first-page":"139","volume":"1786","author":"M Nambiar","year":"2008","unstructured":"Nambiar, M., Kari, V. & Raghavan, S. C. Chromosomal translocations in cancer. Biochim Biophys. Acta 1786, 139\u2013152 (2008).","journal-title":"Biochim Biophys. Acta"},{"key":"35640_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/ng1380","volume":"36","author":"DG Miller","year":"2004","unstructured":"Miller, D. G., Petek, L. M. & Russell, D. W. Adeno-associated virus vectors integrate at chromosome breakage sites. Nat. Genet 36, 767\u2013773 (2004).","journal-title":"Nat. Genet"},{"key":"35640_CR20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/ICU.0b013e3282f0ca54","volume":"18","author":"CM Andreoli","year":"2007","unstructured":"Andreoli, C. M. & Miller, J. W. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr. Opin. Ophthalmol. 18, 502\u2013508 (2007).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"35640_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s40123-021-00354-1","volume":"10","author":"R Anguita","year":"2021","unstructured":"Anguita, R. et al. A Review of Aflibercept Treatment for Macular Disease. Ophthalmol. Ther. 10, 413\u2013428 (2021).","journal-title":"Ophthalmol. Ther."},{"key":"35640_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1101\/gr.219089.116","volume":"27","author":"K Kim","year":"2017","unstructured":"Kim, K. et al. Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration. Genome Res 27, 419\u2013426 (2017).","journal-title":"Genome Res"},{"key":"35640_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41551-020-00656-y","volume":"5","author":"S Ling","year":"2021","unstructured":"Ling, S. et al. Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice. Nat. Biomed. Eng. 5, 144\u2013156 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"35640_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14500","volume":"8","author":"E Kim","year":"2017","unstructured":"Kim, E. et al. In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nat. Commun. 8, 14500 (2017).","journal-title":"Nat. Commun."},{"key":"35640_CR25","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1038\/s41589-021-00868-6","volume":"17","author":"Z Wu","year":"2021","unstructured":"Wu, Z. et al. Programmed genome editing by a miniature CRISPR-Cas12f nuclease. Nat. Chem. Biol. 17, 1132\u20131138 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"35640_CR26","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1093\/nar\/gkv601","volume":"43","author":"DJ Truong","year":"2015","unstructured":"Truong, D. J. et al. Development of an intein-mediated split-Cas9 system for gene therapy. Nucleic Acids Res 43, 6450\u20136458 (2015).","journal-title":"Nucleic Acids Res"},{"key":"35640_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41421-019-0088-8","volume":"5","author":"J Yin","year":"2019","unstructured":"Yin, J. et al. Optimizing genome editing strategy by primer-extension-mediated sequencing. Cell Disco. 5, 18 (2019).","journal-title":"Cell Disco."},{"key":"35640_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nbt.3101","volume":"33","author":"RL Frock","year":"2015","unstructured":"Frock, R. L. et al. Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat. Biotechnol. 33, 179\u2013186 (2015).","journal-title":"Nat. Biotechnol."},{"key":"35640_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.exer.2005.10.012","volume":"82","author":"P Elizabeth Rakoczy","year":"2006","unstructured":"Elizabeth Rakoczy, P., Yu, M. J., Nusinowitz, S., Chang, B. & Heckenlively, J. R. Mouse models of age-related macular degeneration. Exp. Eye Res 82, 741\u2013752 (2006).","journal-title":"Exp. Eye Res"},{"key":"35640_CR30","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/nprot.2013.135","volume":"8","author":"V Lambert","year":"2013","unstructured":"Lambert, V. et al. Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice. Nat. Protoc. 8, 2197\u20132211 (2013).","journal-title":"Nat. Protoc."},{"key":"35640_CR31","doi-asserted-by":"publisher","first-page":"8785","DOI":"10.1093\/nar\/gkab507","volume":"49","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. In-depth assessment of the PAM compatibility and editing activities of Cas9 variants. Nucleic Acids Res 49, 8785\u20138795 (2021).","journal-title":"Nucleic Acids Res"},{"key":"35640_CR32","doi-asserted-by":"publisher","first-page":"8732","DOI":"10.1093\/nar\/gkab686","volume":"49","author":"M Liu","year":"2021","unstructured":"Liu, M. et al. Global detection of DNA repair outcomes induced by CRISPR-Cas9. Nucleic Acids Res 49, 8732\u20138742 (2021).","journal-title":"Nucleic Acids Res"},{"key":"35640_CR33","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","volume":"28","author":"G Turchiano","year":"2021","unstructured":"Turchiano, G. et al. Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq. Cell Stem Cell 28, 1136\u20131147 e1135 (2021).","journal-title":"Cell Stem Cell"},{"key":"35640_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41421-020-00218-1","volume":"6","author":"B Yang","year":"2020","unstructured":"Yang, B. et al. 3D landscape of Hepatitis B virus interactions with human chromatins. Cell Disco. 6, 95 (2020).","journal-title":"Cell Disco."},{"key":"35640_CR35","doi-asserted-by":"crossref","unstructured":"Liu, M. et al. Global detection of DNA repair outcomes induced by CRISPR-Cas9. bioRxiv (2021).","DOI":"10.1101\/2021.02.15.431335"},{"key":"35640_CR36","doi-asserted-by":"crossref","unstructured":"Liu Y. et al. PEM-seq comprehensively quantifies DNA repair outcomes during gene-editing and DSB repair. STAR Protocols 3 (2022).","DOI":"10.1016\/j.xpro.2021.101088"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35640-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35640-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35640-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T06:03:13Z","timestamp":1671688993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35640-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["35640"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-35640-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"assertion":[{"value":"6 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7867"}}